Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.

Ning Yi YapNichole Yue Ting TanChia Jie TanKiley Wei-Jen LohRaymond Chee Hui NgHan Kiat HoAlexandre Chan

Published in: Breast cancer research and treatment (2020)

BDNF plasma level or rs6265 genotype information may facilitate the identification of patients at higher risk of long-term CRCI during survivorship and enable the implementation of early intervention strategies that increase BDNF levels.

Keyphrases

cognitive impairment
stress induced
randomized controlled trial
primary care
young adults
tyrosine kinase